Ocugen, Inc. (OCGN)
1.36
-0.03
(-2.16%)
USD |
NASDAQ |
Aug 24, 16:00
1.36
0.00 (0.00%)
After-Hours: 20:00
Ocugen Shareholders Equity (Quarterly) : -16.56M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.56M |
| March 31, 2026 | 5.805M |
| December 31, 2025 | -12.17M |
| September 30, 2025 | 3.533M |
| June 30, 2025 | 3.052M |
| March 31, 2025 | 15.91M |
| December 31, 2024 | 29.63M |
| September 30, 2024 | 40.63M |
| June 30, 2024 | 16.93M |
| March 31, 2024 | 30.26M |
| December 31, 2023 | 40.56M |
| September 30, 2023 | 58.40M |
| June 30, 2023 | 70.28M |
| March 31, 2023 | 75.80M |
| December 31, 2022 | 73.98M |
| September 30, 2022 | 95.30M |
| June 30, 2022 | 114.11M |
| March 31, 2022 | 131.13M |
| December 31, 2021 | 95.82M |
| September 30, 2021 | 107.11M |
| June 30, 2021 | 116.41M |
| March 31, 2021 | 46.49M |
| December 31, 2020 | 21.55M |
| September 30, 2020 | 14.42M |
| June 30, 2020 | 14.62M |
| Date | Value |
|---|---|
| March 31, 2020 | 7.297M |
| December 31, 2019 | 11.02M |
| September 30, 2019 | -13.09M |
| June 30, 2019 | -8.731M |
| March 31, 2019 | -5.532M |
| December 31, 2018 | -12.71M |
| September 30, 2018 | -9.676M |
| June 30, 2018 | -23.44M |
| March 31, 2018 | -20.07M |
| December 31, 2017 | -11.27M |
| September 30, 2017 | -4.813M |
| June 30, 2017 | 0.806M |
| March 31, 2017 | 6.972M |
| December 31, 2016 | 13.57M |
| September 30, 2016 | 4.036M |
| June 30, 2016 | 12.89M |
| March 31, 2016 | 20.59M |
| December 31, 2015 | 28.20M |
| September 30, 2015 | 36.18M |
| June 30, 2015 | 43.86M |
| March 31, 2015 | 51.22M |
| December 31, 2014 | 54.21M |
| September 30, 2014 | -31.45M |
| June 30, 2014 | -19.70M |
| March 31, 2014 | -21.84M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | 302.07M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Biogen, Inc. | 18.85B |
| Gilead Sciences, Inc. | 11.83B |
| MannKind Corp. | -67.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 124.21M |
| Total Liabilities (Quarterly) | 140.76M |
| Debt to Equity Ratio | -5.314 |
| Current Ratio | 0.8019 |
| Net Debt Paydown Yield | -2.17% |